Clinical Trial Update: Title Fractioned CO2 Laser in the Treatment of Chronic Phase Peyronie's Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating fractioned CO2 laser in treating chronic phase Peyronie's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peyronie Disease

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Peyronies Disease | Phase 1 | Status: RECRUITING